Skip to content
Research/Longevity Anti Aging/Tesofensine

Tesofensine

compound

preliminary evidencePublic

Triple monoamine reuptake inhibitor (SNDRI). Originally developed for Parkinsons/Alzheimers. Significant appetite suppression and weight loss in trials (10.6% weight loss at 0.5mg/day).

Category: Longevity Anti Aging·Updated 5/19/2026
OverviewScienceClinicalSafetyPapersProtocolsOutcomes

Tesofensine

Triple monoamine reuptake inhibitor (SNDRI). Originally developed for Parkinsons/Alzheimers. Significant appetite suppression and weight loss in trials (10.6% weight loss at 0.5mg/day).

ScienceComing soon
ClinicalComing soon
SafetyComing soon
PapersComing soon
ProtocolsComing soon
OutcomesComing soon